The impact of DRG-based management of healthcare facilities on amenable mortality in the European Union

  • Received March 24, 2021;
    Accepted June 3, 2021;
    Published June 10, 2021
  • Author(s)
  • DOI
  • Article Info
    Volume 19 2021, Issue #2, pp. 264-275
  • Cited by
    3 articles

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License

The quality of healthcare management can have a significant impact on the healthcare results achieved. Results of hospital treatment are directly related to the patient’s health and quality of life, thus, it is necessary to examine the impact of different managerial approaches, including the ones related to financing, on indicators of healthcare provision. This article aims to determine whether there is a dependency between DRG-based (diagnosis-related groups) management of healthcare facilities and amenable mortality in the EU countries. Health expenditure per capita was measured in current international $, the number of doctors, nurses, and beds per 1,000 inhabitants were determined as the input factors, while amenable mortality was determined as the outcome factor. The order of the efficiency of the input-output ratio of individual countries was defined using DEA analysis. Subsequently, the countries with the own healthcare financing method were ranked versus the countries with DRG-based management and financing by the mean value between groups using the Mann-Whitney U-test, while no statistically significant dependence was found between them (p-value is 0.522-0.976 for 2012–2017). Thus, even though DRG-based hospital management has various expected benefits, such as better managerial efficiency and transparency of financing, this approach to healthcare financing and management does not significantly impact amenable mortality.

view full abstract hide full abstract
    • Figure 1. ThetaOpt value in selected EU countries according to the selected model
    • Figure 2. Amenable mortality (standardized death rate per 100 000 inhabitants) of selected countries
    • Table 1. ThetaOpt value for selected EU countries for 2012–2017
    • Table 2. Mann-Whitney U-Test of the effectiveness of selected EU countries
    • Data curation
      Rastislav Briestensky
    • Investigation
      Rastislav Briestensky
    • Resources
      Rastislav Briestensky
    • Software
      Rastislav Briestensky
    • Validation
      Rastislav Briestensky
    • Writing – original draft
      Rastislav Briestensky
    • Conceptualization
      Aleksandr Ključnikov
    • Formal Analysis
      Aleksandr Ključnikov
    • Methodology
      Aleksandr Ključnikov
    • Project administration
      Aleksandr Ključnikov
    • Supervision
      Aleksandr Ključnikov
    • Writing – review & editing
      Aleksandr Ključnikov